Maruyama Y - Search Results

1

Possible involvement of cross-linking advanced glycation endproducts in long-term CAPD peritoneal degeneration.

Nakayama M, Yoshimura K, Maruyama Y, Numata M, Hosoya T, Izumi G. Nakayama M, et al. Among authors: maruyama y. Nephrol Dial Transplant. 2004 Jun;19(6):1664-5. doi: 10.1093/ndt/gfh198. Nephrol Dial Transplant. 2004. PMID: 15150373 No abstract available.

2

Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.

Yamamoto R, Otsuka Y, Nakayama M, Maruyama Y, Katoh N, Ikeda M, Yamamoto H, Yokoyama K, Kawaguchi Y, Matsushima M. Yamamoto R, et al. Among authors: maruyama y. Clin Exp Nephrol. 2005 Jun;9(2):148-52. doi: 10.1007/s10157-005-0349-8. Clin Exp Nephrol. 2005. PMID: 15980950

3

[Peritoneal injury and vasculopathy in peritoneal dialysis].

Maruyama Y, Nakayama M. Maruyama Y, et al. Nihon Rinsho. 2005 Jun;63 Suppl 6:430-3. Nihon Rinsho. 2005. PMID: 15999747 Review. Japanese. No abstract available.

4

Encapsulating peritoneal sclerosis is a separate entity: Con.

Nakayama M, Maruyama Y, Numata M. Nakayama M, et al. Among authors: maruyama y. Perit Dial Int. 2005 Feb;25 Suppl 3:S107-9. Perit Dial Int. 2005. PMID: 16048271

5

Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients.

Sherif AM, Nakayama M, Maruyama Y, Yoshida H, Yamamoto H, Yokoyama K, Kawakami M. Sherif AM, et al. Among authors: maruyama y. Nephrol Dial Transplant. 2006 Jun;21(6):1675-81. doi: 10.1093/ndt/gfl054. Epub 2006 Mar 22. Nephrol Dial Transplant. 2006. PMID: 16554330

6

Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.

Maruyama Y, Nakayama M, Yoshimura K, Nakano H, Yamamoto H, Yokoyama K, Lindholm B. Maruyama Y, et al. Nephrol Dial Transplant. 2007 May;22(5):1407-12. doi: 10.1093/ndt/gfl789. Epub 2007 Jan 29. Nephrol Dial Transplant. 2007. PMID: 17264097 Clinical Trial.

7

Relationship between the -374T/A receptor of advanced glycation end products gene polymorphism and peritoneal solute transport status at the initiation of peritoneal dialysis.

Maruyama Y, Numata M, Nakayama M, Matsuo N, Nordfors L, Hosoya T, Lindholm B. Maruyama Y, et al. Ther Apher Dial. 2007 Aug;11(4):301-5. doi: 10.1111/j.1744-9987.2007.00473.x. Ther Apher Dial. 2007. PMID: 17661837

8

Serum beta2 microglobulin (beta2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients.

Yokoyama K, Yoshida H, Matsuo N, Maruyama Y, Kawamura Y, Yamamoto R, Hanaoka K, Ikeda M, Yamamoto H, Nakayama M, Kawaguchi Y, Hosoya T. Yokoyama K, et al. Among authors: maruyama y. Clin Nephrol. 2008 Feb;69(2):121-6. doi: 10.5414/cnp69121. Clin Nephrol. 2008. PMID: 18218305

9

Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis.

Sherif AM, Yoshida H, Maruyama Y, Yamamoto H, Yokoyama K, Hosoya T, Kawakami M, Nakayama M. Sherif AM, et al. Among authors: maruyama y. Ther Apher Dial. 2008 Feb;12(1):33-41. doi: 10.1111/j.1744-9987.2007.00538.x. Ther Apher Dial. 2008. PMID: 18257810

10

Encapsulating peritoneal sclerosis in Japan.

Maruyama Y, Nakayama M. Maruyama Y, et al. Perit Dial Int. 2008 Jun;28 Suppl 3:S201-4. Perit Dial Int. 2008. PMID: 18552256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,419 results

Search Page

Filters